Selected research
Industry Research
Nanobody Discovery Service Industry Research Report 2026
Market perspective
The global Nanobody Discovery Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nanobody Discovery Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nanobody Discovery Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nanobody Discovery Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nanobody Discovery Service include Creative Biolabs, Curia, Sanofi, NanoTag Biotechnologies, Shanghai Medicilon Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Yeasen Biotechnology（Shanghai）Co.,Ltd., Fortis Life Sciences and Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nanobody Discovery Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nanobody Discovery Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nanobody Discovery Service Market by Company
Creative Biolabs
Curia
Sanofi
NanoTag Biotechnologies
Shanghai Medicilon Inc.
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Yeasen Biotechnology（Shanghai）Co.,Ltd.
Fortis Life Sciences
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Biointron Biological Inc.
SAFE Pharmaceutical Technology Co., Ltd.
Abterra Biosciences
Chengdu Apak Biotechnology Co., Ltd.
ICarTab Biomedical Co., Ltd.
Wuhan Daian Biotech Ltd
Nanobody Discovery Service Segment by Type
Screening and Development Services
Engineering and Optimization Services
Production and Expression Services
Other Services
Nanobody Discovery Service Segment by Application
Drug Discovery
Biological Engineering
Clinical Diagnosis
Immune Research
Others
Nanobody Discovery Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanobody Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanobody Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanobody Discovery Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nanobody Discovery Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Screening and Development Services
- Engineering and Optimization Services
- Production and Expression Services
- Other Services
Applications
- Drug Discovery
- Biological Engineering
- Clinical Diagnosis
- Immune Research
- Others
Companies covered
- Creative Biolabs
- Curia
- Sanofi
- NanoTag Biotechnologies
- Shanghai Medicilon Inc.
- Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- Yeasen Biotechnology（Shanghai）Co.,Ltd.
- Fortis Life Sciences
- Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- Biointron Biological Inc.
- SAFE Pharmaceutical Technology Co., Ltd.
- Abterra Biosciences
- Chengdu Apak Biotechnology Co., Ltd.
- ICarTab Biomedical Co., Ltd.
- Wuhan Daian Biotech Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nanobody Discovery Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Screening and Development Services
- 2.2.3 Engineering and Optimization Services
- 2.2.4 Production and Expression Services
- 2.2.5 Other Services
- 2.3 Nanobody Discovery Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Discovery
- 2.3.3 Biological Engineering
- 2.3.4 Clinical Diagnosis
- 2.3.5 Immune Research
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Nanobody Discovery Service Breakdown Data by Type
- 3.1 Global Nanobody Discovery Service Historic Market Size by Type (2021-2026)
- 3.2 Global Nanobody Discovery Service Forecasted Market Size by Type (2027-2032)
4 Nanobody Discovery Service Breakdown Data by Application
- 4.1 Global Nanobody Discovery Service Historic Market Size by Application (2021-2026)
- 4.2 Global Nanobody Discovery Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nanobody Discovery Service Market Perspective (2021-2032)
- 5.2 Global Nanobody Discovery Service Growth Trends by Region
- 5.2.1 Global Nanobody Discovery Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nanobody Discovery Service Historic Market Size by Region (2021-2026)
- 5.2.3 Nanobody Discovery Service Forecasted Market Size by Region (2027-2032)
- 5.3 Nanobody Discovery Service Market Dynamics
- 5.3.1 Nanobody Discovery Service Industry Trends
- 5.3.2 Nanobody Discovery Service Market Drivers
- 5.3.3 Nanobody Discovery Service Market Challenges
- 5.3.4 Nanobody Discovery Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nanobody Discovery Service Players by Revenue
- 6.1.1 Global Top Nanobody Discovery Service Players by Revenue (2021-2026)
- 6.1.2 Global Nanobody Discovery Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Nanobody Discovery Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nanobody Discovery Service Head Office and Area Served
- 6.4 Global Nanobody Discovery Service Players, Product Type & Application
- 6.5 Global Nanobody Discovery Service Manufacturers Established Date
- 6.6 Global Nanobody Discovery Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nanobody Discovery Service Market Size (2021-2032)
- 7.2 North America Nanobody Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nanobody Discovery Service Market Size by Country (2021-2026)
- 7.4 North America Nanobody Discovery Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nanobody Discovery Service Market Size (2021-2032)
- 8.2 Europe Nanobody Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nanobody Discovery Service Market Size by Country (2021-2026)
- 8.4 Europe Nanobody Discovery Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nanobody Discovery Service Market Size (2021-2032)
- 9.2 Asia-Pacific Nanobody Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nanobody Discovery Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nanobody Discovery Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nanobody Discovery Service Market Size (2021-2032)
- 10.2 South America Nanobody Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nanobody Discovery Service Market Size by Country (2021-2026)
- 10.4 South America Nanobody Discovery Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nanobody Discovery Service Market Size (2021-2032)
- 11.2 Middle East & Africa Nanobody Discovery Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nanobody Discovery Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nanobody Discovery Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Creative Biolabs
- 12.1.1 Creative Biolabs Company Information
- 12.1.2 Creative Biolabs Business Overview
- 12.1.3 Creative Biolabs Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.1.4 Creative Biolabs Nanobody Discovery Service Product Portfolio
- 12.1.5 Creative Biolabs Recent Developments
- 12.2 Curia
- 12.2.1 Curia Company Information
- 12.2.2 Curia Business Overview
- 12.2.3 Curia Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.2.4 Curia Nanobody Discovery Service Product Portfolio
- 12.2.5 Curia Recent Developments
- 12.3 Sanofi
- 12.3.1 Sanofi Company Information
- 12.3.2 Sanofi Business Overview
- 12.3.3 Sanofi Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.3.4 Sanofi Nanobody Discovery Service Product Portfolio
- 12.3.5 Sanofi Recent Developments
- 12.4 NanoTag Biotechnologies
- 12.4.1 NanoTag Biotechnologies Company Information
- 12.4.2 NanoTag Biotechnologies Business Overview
- 12.4.3 NanoTag Biotechnologies Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.4.4 NanoTag Biotechnologies Nanobody Discovery Service Product Portfolio
- 12.4.5 NanoTag Biotechnologies Recent Developments
- 12.5 Shanghai Medicilon Inc.
- 12.5.1 Shanghai Medicilon Inc. Company Information
- 12.5.2 Shanghai Medicilon Inc. Business Overview
- 12.5.3 Shanghai Medicilon Inc. Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.5.4 Shanghai Medicilon Inc. Nanobody Discovery Service Product Portfolio
- 12.5.5 Shanghai Medicilon Inc. Recent Developments
- 12.6 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- 12.6.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
- 12.6.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
- 12.6.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.6.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio
- 12.6.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
- 12.7 Yeasen Biotechnology（Shanghai）Co.,Ltd.
- 12.7.1 Yeasen Biotechnology（Shanghai）Co.,Ltd. Company Information
- 12.7.2 Yeasen Biotechnology（Shanghai）Co.,Ltd. Business Overview
- 12.7.3 Yeasen Biotechnology（Shanghai）Co.,Ltd. Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.7.4 Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Product Portfolio
- 12.7.5 Yeasen Biotechnology（Shanghai）Co.,Ltd. Recent Developments
- 12.8 Fortis Life Sciences
- 12.8.1 Fortis Life Sciences Company Information
- 12.8.2 Fortis Life Sciences Business Overview
- 12.8.3 Fortis Life Sciences Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.8.4 Fortis Life Sciences Nanobody Discovery Service Product Portfolio
- 12.8.5 Fortis Life Sciences Recent Developments
- 12.9 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- 12.9.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
- 12.9.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
- 12.9.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.9.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio
- 12.9.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
- 12.10 Biointron Biological Inc.
- 12.10.1 Biointron Biological Inc. Company Information
- 12.10.2 Biointron Biological Inc. Business Overview
- 12.10.3 Biointron Biological Inc. Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.10.4 Biointron Biological Inc. Nanobody Discovery Service Product Portfolio
- 12.10.5 Biointron Biological Inc. Recent Developments
- 12.11 SAFE Pharmaceutical Technology Co., Ltd.
- 12.11.1 SAFE Pharmaceutical Technology Co., Ltd. Company Information
- 12.11.2 SAFE Pharmaceutical Technology Co., Ltd. Business Overview
- 12.11.3 SAFE Pharmaceutical Technology Co., Ltd. Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.11.4 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product Portfolio
- 12.11.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Developments
- 12.12 Abterra Biosciences
- 12.12.1 Abterra Biosciences Company Information
- 12.12.2 Abterra Biosciences Business Overview
- 12.12.3 Abterra Biosciences Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.12.4 Abterra Biosciences Nanobody Discovery Service Product Portfolio
- 12.12.5 Abterra Biosciences Recent Developments
- 12.13 Chengdu Apak Biotechnology Co., Ltd.
- 12.13.1 Chengdu Apak Biotechnology Co., Ltd. Company Information
- 12.13.2 Chengdu Apak Biotechnology Co., Ltd. Business Overview
- 12.13.3 Chengdu Apak Biotechnology Co., Ltd. Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.13.4 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product Portfolio
- 12.13.5 Chengdu Apak Biotechnology Co., Ltd. Recent Developments
- 12.14 ICarTab Biomedical Co., Ltd.
- 12.14.1 ICarTab Biomedical Co., Ltd. Company Information
- 12.14.2 ICarTab Biomedical Co., Ltd. Business Overview
- 12.14.3 ICarTab Biomedical Co., Ltd. Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.14.4 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product Portfolio
- 12.14.5 ICarTab Biomedical Co., Ltd. Recent Developments
- 12.15 Wuhan Daian Biotech Ltd
- 12.15.1 Wuhan Daian Biotech Ltd Company Information
- 12.15.2 Wuhan Daian Biotech Ltd Business Overview
- 12.15.3 Wuhan Daian Biotech Ltd Revenue in Nanobody Discovery Service Business (2021-2026)
- 12.15.4 Wuhan Daian Biotech Ltd Nanobody Discovery Service Product Portfolio
- 12.15.5 Wuhan Daian Biotech Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst